Fluorogenic probes and their use in quantitative detection of target RNA sequences
Disclosed are compositions, reagents, methods, assays, and kits for quantitative and sensitive detection of target ribonucleic acid (RNA) sequences, particularly target RNA sequences that contain RNA spliced sites, hairpin stem-loops or other topological configurations of RNA secondary, tertiary, and quaternary structure, as well as linear RNA sequences. In some embodiments, fluorogenic modified-backbone oligonucleotide probes are employed for specific sequence hybridization across the target site, followed by chemical autoligation to produce a fluorescent molecule within the ligated probes. The autoligation detection reaction is performed isothermally or through thermocycling.
1. A fluorogenic method for quantitative detection of a target ribonucleic acid (RNA) sequence in a test sample comprising:
a. adding to the sample a fluorogenic nucleic acid composition comprising an excess of at least one pair of oligonucleotide probes with an upstream first probe and a downstream second probe complementary to and capable of specifically binding the target RNA in an upstream and downstream portion of the target RNA, respectively, wherein
both probes are covalently bound to a nonfluorescent moiety;
b. optionally exposing the sample to denaturing conditions;
c. hybridizing the probes in the fluorogenic nucleic acid composition wherein:
i. the at least one pair of oligonucleotide probes bind to a target RNA, and
ii. the nonfluorescent moiety bound to the first probe chemically reacts with the nonfluorescent moiety on the second probe to form a fluorescent moiety covalently connecting the two probes when both probes of the probe set hybridize to the target RNA sequence;
d. allowing the probes and covalently bound fluorescent moiety bridging the probes to fall off the target RNA under temperature conditions in which the covalently connected probe pair is capable of falling off the target RNA and wherein the fluorescent moiety covalently connecting the two probes remains intact;
e. repeating step c;
f. optionally repeating step d and c one or more times; and
g. detecting the amount of fluorescence emitted by the fluorescent moiety in the sample covalently connecting the two probes.
2. The method of claim 1 , wherein the target RNA sequence is HIV-1, HIV-2, Ebola hemorrhagic fever, SARS, influenza, hepatitis C, West Nile, polio, measles, CMV, Herpes, or Zika virus.
3. The method of claim 1 , wherein in step b the sample is exposed to denaturing conditions.
4. The method of claim 1 , wherein the method further comprises normalizing the amount of fluorescence that is detected in the test sample to the amount of fluorescence that is detected in a negative control sample that contains a non-target RNA sequence and calculating the amount of each target RNA sequence in the test sample from the normalized amount of fluorescence detected.
5. The method of claim 1 , wherein the method further comprises normalizing the amount of fluorescence that is detected in the test sample to the amount of fluorescence that is detected in a positive control sample that contains a target RNA sequence of known concentration and calculating the amount of each target RNA sequence in the test sample from the normalized amount of fluorescence detected.
6. The fluorogenic method of claim 1 , further comprising administering an anti-HIV medication to a patient and performing the fluorogenic method on samples obtained from the patient before and after the medication was administered.
7. The fluorogenic method of claim 1 , wherein the sample is obtained from a patient, further comprising measuring a level of D4-A7 spliced site in the sample, wherein D4-A7 splicing indicates a latent HIV reservoir, and administering an anti-HIV medication to the patient if the patient is found to have a latent HIV reservoir.
8. The method of claim 1 , wherein step d occurs under denaturing conditions.
9. The method of claim 8 , wherein step d occurs at a temperature of from 90° C. to 100° C.
10. The method of claim 1 , wherein step d occurs under isothermal conditions.
11. The method of claim 10 , wherein step d occurs at a temperature of from 20° C. to 70° C.
12. The method of claim 1 , wherein steps c-d occur under thermocycling conditions.
13. The method of claim 12 , wherein step d occurs at a temperature of from 90° C. to 100° C. and step c occurs at a temperature of from 20° C. to 70° C.